Simvastatin enhances the efficacy of nilotinib in chronic myeloid leukaemia by post-translational modification and drug transporter modulation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Simvastatin enhances the efficacy of nilotinib in chronic myeloid leukaemia by post-translational modification and drug transporter modulation

Published:2021-02-09 Issue:5 Volume:32 Page:526-536
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Asari Kartini,Sun Wen Tian,Kok Ze Hui,Lam Yi Hui,Ng Bee Ling,Saunders Verity,White Deborah L.,Chuah Charles,Xiang Wei

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference61 articles.

1. Chronic myelogenous leukemia (CML): resistance to tyrosine kinase inhibitors.;Hochhaus;Ann Oncol,2006

2. Targeted CML therapy: controlling drug resistance, seeking cure.;O’Hare;Curr Opin Genet Dev,2006

3. Acquired resistance to tyrosine kinase inhibitors during cancer therapy.;Engelman;Curr Opin Genet Dev,2008

4. Managing resistance in chronic myeloid leukemia.;Roychowdhury;Blood Rev,2011

5. Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance.;Mahon;Blood,2000

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Statin Lipophilicity on the Proliferation of Hepatocellular Carcinoma Cells;Biology;2024-06-19

2. Drug repurposing for cancer therapy;Signal Transduction and Targeted Therapy;2024-04-19

3. Biphasic effects of statins on neuron cell functions under oxygen–glucose deprivation and normal culturing conditions via different mechanisms;Pharmacology Research & Perspectives;2022-08-27

4. Simvastatin potentiates the cell-killing activity of imatinib in imatinib-resistant chronic myeloid leukemia cells mainly through PI3K/AKT pathway attenuation and Myc downregulation;European Journal of Pharmacology;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3